Xule Feng

Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer.

Yu-bo Zhou, Minjia Tan, Ruimin Huang, 2021, Journal of medicinal chemistry.